“…Currently, the PhenoMatrix™ (Copan Italia, Brescia, Italy) application provides an assessment of an agar plate in conjunction with expert rules where the user must accept the decision from the algorithm to proceed with reporting or further work, with published studies covering group B Streptococcus and Streptococcus pyogenes ( Van et al, 2019 ; Baker et al, 2020 ). The APAS ® Independence (Clever Culture Systems) is currently the only system with FDA clearance as a class II medical device which is diagnostic for a negative no growth result from urine samples ( Glasson et al, 2017 ), and for no significant growth when used in MRSA detection ( Gammel et al, 2021 ). In these cases, human intervention is only required for significant growths.…”